↑↑↑查找国内细胞行业公司↑↑↑请点击上方图片50岁男性患者接受1.2亿脐带间充质干细胞输注 接受干细胞治疗后“感觉好多了” 已有数千例患者证实间充质干细胞的潜力 【参考文献】 [1] Case report: effect of umbilical cord mesenchymal stem cells on immunoglobulin A nephropathy after acute renal failure. https:///files/ajtr/14/7/ajtr0142375.pdf [2] Immunological drivers of IgA nephropathy: exploring the mucosa-kidney link. https://pubmed.ncbi.nlm./34821031/ [3] Care of the Critically Ill Emergency Department Patient with Acute Kidney Injury https://xueshu.baidu.com/usercenter/paper/show?paperid=fe82437fdaa28cc000af89f227818383&site=xueshu_se&hitarticle=1 [4] Ponticelli C and Locatelli F. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. https://pubmed.ncbi.nlm./14694168/ [5] Mehta RL. Renal Recovery after acute kidney injury and long-term outcomes: is time of the essence? https://pubmed.ncbi.nlm./32282043/ [6] Five-year outcomes of severe acute kidney injury requiring renal replacement therapy. https://pubmed.ncbi.nlm./18408072/ [7] Paracrine mechanisms of mesenchymal stromal cells in angiogenesis. https://pubmed.ncbi.nlm./32215017/ [8] Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. https://pubmed.ncbi.nlm./23133515/ [9] Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis. https://pubmed.ncbi.nlm./31989101/ [10] Mesenchymal stem cells: a promising therapeutic tool for acute kidney injury. https://pubmed.ncbi.nlm./30976980/ [11] Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. https://pubmed.ncbi.nlm./17332507/ 本文为知识性科普,仅供学习、交流,请勿用作商业用途。 |
|